Publications by authors named "Huating Zeng"

Claim this Profile
O
Oxymatrine for treating atopic dermatitis: Network pharmacology, bioinformatics, metabolomics, and experimental validation.
Jin Huang, Hongxia Li, Jiqiang Liang, Yue Zhang, Ruipei Yang, Huating Zeng

Int Immunopharmacol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcranial alternating current stimulation for treating spinocerebellar ataxia type 3: A randomized controlled trial.
Xinyuan Chen, Xia Liu, Wei Lin, Lin Zhang, Xiaoping Cheng, Huating Zeng

Cell Rep Med· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An icaritin-loaded microemulsion based on coix oil for improved pharmacokinetics and enhanced antitumor efficacy.
Huating Zeng, Xiaoqi Li, Yuping Liu, Xia Li, Ding Qu

Drug Deliv· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A CFH peptide-decorated liposomal oxymatrine inactivates cancer-associated fibroblasts of hepatocellular carcinoma through epithelial-mesenchymal transition reversion.
Jian Guo, Huating Zeng, Xinmeng Shi, Tao Han, Yimin Liu

J Nanobiotechnology· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicomponent thermosensitive lipid complexes enhance desmoplastic tumor therapy through boosting anti-angiogenesis and synergistic strategy.
Jian Guo, Huating Zeng, Yimin Liu, Xinmeng Shi, Yuping Liu

Int J Pharm· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Development of preparation process of icaritin-coix seed oil microemulsion based on quality by design concept].
Hua-Ting Zeng, Jian Guo, Cong-Yan Liu, Ting Xu, Rui-Yun Li

Zhongguo Zhong Yao Za Zhi· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging Nano Drug Delivery Systems Targeting Cancer-Associated Fibroblasts for Improved Antitumor Effect and Tumor Drug Penetration.
Jian Guo, Huating Zeng, Yan Chen

Mol Pharm· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis